Search
for
Sort by
Research 241–270 of 1000+
- <i>Saccharomyces cerevisiae</i> BLYAS, a New Bioluminescent Bioreporter for Detection of Androgenic Compounds
- Clinical development and management of adverse events associated with FGFR inhibitors
- Current applications of high-frequency ultrasonography in dermatology
- Research Advances in Electrospun Nanofiber Membranes for Non-Invasive Medical Applications
- Albendazole treatment of echinococcosis in humans: Effects on microsomal metabolism and drug tolerance
- Coronavirus Infection and Cholesterol Metabolism
- Valence-engineered catalysis-selectivity regulation of molybdenum oxide nanozyme for acute kidney injury therapy and post-cure assessment
- Adverse Reactions to Oral Retinoids An Update
- Adverse Cutaneous Reactions to Mood Stabilizers
- Ketoconazole Therapy for Women with Acne and/or Hirsutism
- Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen
- Clinical picture, diagnosis, treatment and outcome of severe acute respiratory syndrome (SARS) in children
- Cushing's syndrome due to pharmacological interaction in a cystic fibrosis patient
- An unusual presentation of dermatomyositis: The type Wong variant revisited
- Chapter 7 Reproductive Dysfunction in Women with Epilepsy
- First-in-human phase 1 study of ETC-159 an oral PORCN inhbitor in patients with advanced solid tumours.
- Gender-Affirming Hormone Therapy for Transgender Females
- TrichoScan: combining epiluminescence microscopy with digital image analysis for the measurement of hair growth in vivo.
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- Scalp immersion proxigraphy (SIP): an improved imaging technique for phototrichogram analysis*
- Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Testosterone therapy in men: Clinical and pharmacological perspectives
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- Optical Coherent Tomography for in vivo Determination of Changes in Hair Cross Section and Diameter during Treatment with Glucocorticosteroids – A Simple Method to Screen for Doping Substances?
- Topical Tacrolimus in the Treatment of Erosive Pustular Dermatosis of the Scalp
- Cutaneous manifestations of metabolic diseases: uncommon presentations
- Hair loss at injection sites of mesotherapy for alopecia
- A regulatory perspective on pharmacokinetic/pharmacodynamic modelling
- Localized cutaneous necrosis associated with the antiphospholipid syndrome